​​

TYLER SEIBERT, MD, PHD

ASSISTANT PROFESSOR

  • BS Bioengineering | University of California Berkeley 2005
  • PhD Bioengineering | University of California San Diego 2011
  • MD University of California San Diego 2013
  • Residency University of California San Diego 2018
  • Clinical Focus ​Prostate Cancer, Genitourinary Cancers, and Stereotactic Radiosurgery​

Dr. Tyler Seibert is an Assistant Professor in the Division of Radiation Oncology and a member of the RMAS Center for Precision Radiation Medicine (CPRM). He also serves as an Associate Director of the UC San Diego Center for Translational Imaging and Precision Medicine (CTIPM). He is an active member of the GU/Prostate Cancer and CNS Tumor Disease Teams and his clinic is in La Jolla within the Moores Cancer Center.

He is a dedicated clinical translational researcher with interests in both novel imaging research and genetics. He is a recipient of a K08 Award from the National Institutes of Health (NIH) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) to explore the utility of whole-body RSI MR imaging in patients with high-risk/metastatic prostate cancer. His research group also uses advanced quantitative imaging tools to measure radiation effects on the brain. In the genomics space, Dr. Seibert heads UC San Diego’s participation in an international prostate cancer genetics consortium (PRACTICAL). The Seibert Lab develops and validates genetic risk models to identify men at risk of developing aggressive prostate cancer and to predict at what age they should undergo screening. He has published many articles in prominent scientific journals, including Radiology, Cancer, and the BMJ. He has presented at numerous national and international conferences and symposia.

In addition to his research, Dr. Seibert is a dedicated physician who treats patients with a wide variety of tumors, including Brain Tumors and Prostate Cancer. He serves on committees for the Radiological Society of North America (RSNA), the American Society for Radiation Oncology (ASTRO), and the UC San Diego campus-wide Academic Senate.